NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-AI-23-051 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-NS-24-009 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) supports the optimization of promising genome editing-based therapeutic leads for Alzheimer's Disease-Related Dementias (ADRD), towards IND-enabling studies. Specifically, it supports the characterization and optimization of therapeutic lead(s) that show promise as potential genome editing therapeutics, as evidenced by convincing proof-of-concept studies in appropriate models. At the end of the funding period, successful projects will have optimized a genome editing therapeutic candidate with demonstrated bioactivity, manufacturability, biodistribution, in vivo efficacy, and/or target engagement (measurement of proximal downstream effects) and optimal dosing, combined with other properties consistent with the desired clinical application. This NOFO is not specific for any one or group within the ADRD spectrum of disorders. Disorders include; Frontotemporal dementia (FTD), Lewy body dementias (LBD) (including Dementia with Lewy bodies (DLB), Parkinson Disease Dementia (PDD)), Vascular contributions to Cognitive Impairment and Dementia (VCID), and Multiples Etiology Dementias (MED).
Funding Opportunity RFA-NS-24-025 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is toinvite applications that aggregate and analyze existing data in the COVID-19 Neuro Databank-Biobank (NeuroCOVIDProject).TheNeuroCOVIDProject was establishedin 2020 to serve as a robust national resource to understand theneurological complicationsassociated with COVID-19 and the effects of COVID-19 on pre-existing neurological conditions. The NeuroCOVID Project has collected and curated a wide range of data from the United States and international sites. This NOFO encourages hypothesis-driven applications to further scientific knowledge of neurological complications ofCOVID-19 by using this de-identified database. Thedata may be combined with data from other U.S. and International databases for analyses.However,collection of new primary data from those affected by COVID-19 or comparison cohorts isNOT covered by this NOFO.
Notice NOT-DE-23-008 from the NIH Guide for Grants and Contracts
Notice NOT-HS-23-017 from the NIH Guide for Grants and Contracts
Notice NOT-HS-23-016 from the NIH Guide for Grants and Contracts
Notice NOT-EY-23-008 from the NIH Guide for Grants and Contracts
Notice NOT-ES-23-012 from the NIH Guide for Grants and Contracts
Notice NOT-GM-23-023 from the NIH Guide for Grants and Contracts
Notice NOT-MH-23-355 from the NIH Guide for Grants and Contracts
Notice NOT-AA-23-011 from the NIH Guide for Grants and Contracts
Notice NOT-TR-23-022 from the NIH Guide for Grants and Contracts
Notice NOT-HL-23-093 from the NIH Guide for Grants and Contracts
Notice NOT-HL-23-092 from the NIH Guide for Grants and Contracts
Notice NOT-HL-23-094 from the NIH Guide for Grants and Contracts
Notice NOT-HL-23-095 from the NIH Guide for Grants and Contracts
Notice NOT-AI-23-046 from the NIH Guide for Grants and Contracts
Notice NOT-NS-23-082 from the NIH Guide for Grants and Contracts
Notice NOT-AI-23-049 from the NIH Guide for Grants and Contracts
Notice NOT-OD-23-149 from the NIH Guide for Grants and Contracts